Financhill
Buy
61

MSFT Quote, Financials, Valuation and Earnings

Last price:
$510.15
Seasonality move :
2.02%
Day range:
$507.43 - $514.64
52-week range:
$344.79 - $514.64
Dividend yield:
0.64%
P/E ratio:
39.42x
P/S ratio:
14.11x
P/B ratio:
11.78x
Volume:
21.2M
Avg. volume:
18.8M
1-year change:
15.82%
Market cap:
$3.8T
Revenue:
$245.1B
EPS (TTM):
$12.94

Earnings Data

Next earnings date for MSFT
Jul 30
2025
Most recent earnings per share
$3.46
Beat by $0.24
(Apr 30/2025)
Consensus Estimate
$3.22
(Apr 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MSFT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $74.1B -- -- $3.55 --
07/30/2025 Q2 $73.8B -- -- $3.38 --
04/30/2025 Q1 $68.4B $70.1B $3.46 $3.22 $0.24
01/29/2025 Q4 $68.8B $69.6B $3.23 $3.12 $0.11
10/30/2024 Q3 $64.6B $65.6B $3.30 $3.11 $0.19
07/30/2024 Q2 $64.4B $64.7B $2.95 $2.94 $0.01
04/25/2024 Q1 $60.9B $61.9B $2.94 $2.84 $0.10
01/30/2024 Q4 $61.1B $62B $2.93 $2.77 $0.16
10/24/2023 Q3 $54.5B $56.5B $2.99 $2.65 $0.34
07/25/2023 Q2 $55.5B $56.2B $2.69 $2.55 $0.14
04/25/2023 Q1 -- $52.9B $2.45 -- --
01/24/2023 Q4 -- $52.7B $2.20 -- --
10/25/2022 Q3 -- $50.1B $2.35 -- --
07/26/2022 Q2 -- $51.9B $2.23 -- --
04/26/2022 Q1 -- $49.4B $2.22 -- --
01/25/2022 Q4 -- $51.7B $2.48 -- --
10/26/2021 Q3 -- $45.3B $2.71 -- --
07/27/2021 Q2 -- $46.2B $2.17 -- --
04/27/2021 Q1 -- $41.7B $2.03 -- --
01/26/2021 Q4 -- $43.1B $2.03 -- --
10/27/2020 Q3 -- $37.2B $1.82 -- --
07/22/2020 Q2 -- $38B $1.46 -- --
04/29/2020 Q1 -- $35B $1.40 -- --
01/29/2020 Q4 -- $36.9B $1.51 -- --
10/23/2019 Q3 -- $33.1B $1.38 -- --
07/18/2019 Q2 -- $33.7B $1.71 -- --
04/24/2019 Q1 -- $30.6B $1.14 -- --
01/30/2019 Q4 -- $32.5B $1.08 -- --
10/24/2018 Q3 -- $29.1B $1.14 -- --
07/19/2018 Q2 -- $30.1B $1.14 -- --
04/27/2018 Q1 -- $26.8B $0.95 -- --
01/31/2018 Q4 -- $28.9B -$0.82 -- --
10/26/2017 Q3 -- $24.5B $0.84 -- --
07/20/2017 Q2 -- $25.6B $0.83 -- --
04/27/2017 Q1 -- $23.2B $0.70 -- --
01/26/2017 Q4 -- $25.8B $0.80 -- --
10/20/2016 Q3 -- $21.9B $0.72 -- --
07/19/2016 Q2 -- $26.4B $0.39 -- --
04/21/2016 Q1 -- $20.5B $0.47 -- --
01/28/2016 Q4 -- $23.8B $0.62 -- --
10/22/2015 Q3 -- $20.4B $0.61 -- --

Microsoft Earnings Questions

  • How Much did Microsoft Generate in Revenue Last Quarter?

    Microsoft reported $70.1B worth of top line sales in its most recent quarter.

  • Did Microsoft Beat Earnings Last Quarter?

    Microsoft announced earnings per share of $3.46 which represents a beat of analyst forecast a $3.22 per share.

  • Is Microsoft Profitable?

    Microsoft reported $48.1B that represents $6.45 per share over the last quarter.

  • What is the Analyst Consensus for Microsoft EPS Next Year?

    Microsoft's earnings are forecast to grow from $11.80 per share to $13.42 per share next year representing an increase of 28.22%.

  • When is Microsoft's Earnings Date?

    Microsoft's next earnings date is July 30, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Archer Aviation Stock Going Up?
Why Is Archer Aviation Stock Going Up?

Archer Aviation (NYSE:ACHR) is an aviation startup that is working…

How High Will Brown Forman Stock Go?
How High Will Brown Forman Stock Go?

On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock